Acute Pain
Volume 11, Issue 3 , Pages 143-144 , December 2009

Continuing use of droperidol in patient-controlled analgesia with morphine

Received 3 September 2009

References 

  1. Tramer MR, Walder B. Efficacy and adverse effects of prophylactic antiemetics during patient-controlled analgesia therapy: a quantitative systematic review. Anesthesia and Analgesia. 1999;88(6):1354–1361
  2. McCormick CG. FDA alert: current FDA report on droperidol status and basis for “Black Box” warning. ASA Newsletter. 2002;66:19–20
  3. Gan TJ, White PF, Scuderi PE, Watcha MF, Kovac A. FDA “Black Box” warning regarding use of droperidol for postoperative nausea and vomiting: is it justified?. Anesthesiology. 2002;97:287
  4. Lamond CT, Robinson DL, Boyd JD, Cashman JN. Addition of droperidol to morphine administered by the patient controlled analgesia method: what is the optimal dose?. European Journal of Anaesthesiology. 1998;15:304–309

PII: S1366-0071(09)00046-1

doi: 10.1016/j.acpain.2009.09.002

Acute Pain
Volume 11, Issue 3 , Pages 143-144 , December 2009

Article Tools

* Image Usage & Resolution